FREDERICK, MD–(Marketwired – Mar 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the Australian Pharmacy Professional Conference and Trade Exhibition. The conference and trade exhibition is the largest pharmaceutical event in Australia with 232 exhibitors … Continue Reading
Category
News
BioElectronics Announces ActiPatch® Available on Amazon
FREDERICK, MD, USA, BioElectronics Corporation (OTC Pink: BIEL), February 9, 2017 8:30 AM, the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device … Continue Reading
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy
FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading
BioElectronics Company Update: Sept 30, 2016
Reflexonic, LLC On September 9, 2016, we signed an Exclusive Licensing and Supply Agreement with Reflexonic, LLC. Reflexonic sells and distributes urological medical devices, products, and related medical products. Reflexonic will assist in the development of urological products for the treatment of overactive bladder, interstitial cystitis and bladder pain syndrome by providing device therapeutic specifications, … Continue Reading
BioElectronics Company Update: August 22, 2016
Pending FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. Our … Continue Reading
Your Voice Matters
How is your chronic pain treated? If you feel your illness is misunderstood and you could use better or less costly treatments, sign this petition today asking the White House to implement the National Pain Strategy. The National Fibromyalgia & Chronic Pain Association (NFMCPA), with the Consumer Pain Advocacy Task Force (CPATF), recently launched a … Continue Reading
BioElectronics Company Update – July 22, 2016
Pending U.S. FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. … Continue Reading
BioElectronics Company Update July 7, 2016
BioElectronics Expands Pulsed Shortwave Technology Thursday, July 7, 2016 Dr. Sree Koneru, our Director of Electroceutical Research working at the Clinical Science and Engineering Research Center, New York State University, Binghamton, New York, has made significant advances in our understanding and development of pulsed shortwave technology. A series of experiments using a unique testing device … Continue Reading
BioElectronics Company Update – June 8, 2016
US FDA Meeting On May 24, 2016, we met with FDA reviewer for our ActiPatch device, key management from the Physical Medicine and Neurotherapeutic Devices Branch, senior leadership from the Division of Neurological and Physical Medicine Devices, and a Regulatory Advisor, Office of Device Evaluation. BioElectronics Attendees: Richard Staelin, PhD, Chairman of Board, PhD in … Continue Reading
Bioelectronics Compay Update April 7, 2016
BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget” The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. A panel of six independent over-the-counter marketing experts evaluated the seven … Continue Reading